Crossref
journal-article
Wiley
International Journal of Cancer (311)
Authors
11
- Young Hwa Soung (first)
- Jong Woo Lee (additional)
- Su Young Kim (additional)
- Young Pil Wang (additional)
- Keon Hyun Jo (additional)
- Seok Whan Moon (additional)
- Won Sang Park (additional)
- Suk Woo Nam (additional)
- Jung Young Lee (additional)
- Nam Jin Yoo (additional)
- Sug Hyung Lee (additional)
References
24
Referenced
87
10.1038/nrc1360
/ Nat Rev Cancer / The discovery of receptor tyrosine kinases: targets for cancer therapy by Gschwind (2004)10.1016/S0014-4827(02)00101-5
/ Exp Cell Res / The deaf and the dumb: the biology of ErbB-2 and ErbB-3 by Citri (2003)10.1016/S0014-4827(02)00099-X
/ Exp Cell Res / The ErbB receptors and their role in cancer progression by Holbro (2003)10.1016/S0014-4827(02)00098-8
/ Exp Cell Res / Epidermal growth factor receptor: mechanisms of activation and signaling by Jorissen (2003)10.1158/0008-5472.CAN-04-2818
/ Cancer Res / Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications by Kosaka (2004)10.1056/NEJMoa040938
/ N Engl J Med / Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib by Lynch (2004)10.1126/science.1099314
/ Science / EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy by Paez (2004)10.1073/pnas.0405220101
/ Proc Natl Acad Sci USA / EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib by Pao (2004)10.1038/431525b
/ Nature / Lung cancer: intragenic ERBB2 kinase mutations in tumours by Stephens (2004)10.1158/0008-5472.CAN-04-4235
/ Cancer Res / Somatic mutations of the HER2 kinase domain in lung adenocarcinomas by Shigematsu (2005)10.1016/S0014-4827(02)00100-3
/ Exp Cell Res / ErbB-4: mechanism of action and biology by Carpenter (2003)10.1038/ng1571
/ Nat Genet / A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer by Stephens (2005)10.1007/s004280050253
/ Virchows Arch / A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections by Lee (1998)10.1038/sj.onc.1206749
/ Oncogene / BRAF and KRAS mutations in stomach cancer by Lee (2003)10.1038/sj.onc.1208304
/ Oncogene / PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas by Lee (2005)10.1002/ijc.20591
/ Int J Cancer / Absence of EGFR mutation in the kinase domain in common human cancers besides nonsmall cell lung cancer by Lee (2005)10.1038/nrc1299
/ Nat Rev Cancer / A census of human cancer genes by Futreal (2004)10.1038/nature00766
/ Nature / Mutations of the BRAF gene in human cancer by Davies (2002)10.1126/science.1096502
/ Science / High frequency of mutations of the PIK3CA gene in human cancers by Samuels (2004)10.1093/jnci/83.14.1024
/ J Natl Cancer Inst / Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung by Slebos (1991)10.1097/00000478-198405000-00007
/ Am J Surg Pathol / Early gastric cancer by Bogomoletz (1984)10.1053/sonc.2002.34047
/ Semin Oncol / HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer by Arteaga (2002)10.1056/NEJM200104053441402
/ N Engl J Med / Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome by Druker (2001){'key': '10.1002/ijc.21507-BIB24|cit25', 'first-page': '5749', 'article-title': 'ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy', 'volume': '62', 'author': 'Wakeling', 'year': '2002', 'journal-title': 'Cancer Res'}
/ Cancer Res / ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy by Wakeling (2002)
Dates
Type | When |
---|---|
Created | 19 years, 11 months ago (Sept. 26, 2005, 12:54 p.m.) |
Deposited | 4 years, 2 months ago (July 1, 2021, 1:51 p.m.) |
Indexed | 4 months, 4 weeks ago (April 9, 2025, 5:48 a.m.) |
Issued | 19 years, 11 months ago (Sept. 26, 2005) |
Published | 19 years, 11 months ago (Sept. 26, 2005) |
Published Online | 19 years, 11 months ago (Sept. 26, 2005) |
Published Print | 19 years, 5 months ago (March 15, 2006) |
@article{Soung_2005, title={Somatic mutations of theERBB4kinase domain in human cancers}, volume={118}, ISSN={0020-7136}, url={http://dx.doi.org/10.1002/ijc.21507}, DOI={10.1002/ijc.21507}, number={6}, journal={International Journal of Cancer}, publisher={Wiley}, author={Soung, Young Hwa and Lee, Jong Woo and Kim, Su Young and Wang, Young Pil and Jo, Keon Hyun and Moon, Seok Whan and Park, Won Sang and Nam, Suk Woo and Lee, Jung Young and Yoo, Nam Jin and Lee, Sug Hyung}, year={2005}, month=sep, pages={1426–1429} }